A Cold Shower For Viagra: How Congress Can Chill A Market

Pfizer, Lilly and the other marketers of drugs for erectile dysfunction are kicked out of Medicare and Medicaid. Viagra and the other brands may be the first victims of the backlash against DTC advertising. They are also a case study in how Congress can--and well--make mischief under the Medicare program.

By Michael McCaughan

Where is Bob Dole when you need him? Congress has cut off federal spending on drugs to treat erectile dysfunction, claiming the Treasury will save $690 million over the next five years by refusing to pay for Viagra and its competitors under the two largest federally funded health programs: Medicaid and Medicare

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Platform Technologies

More from Advanced Technologies